首页 › 基金 › Redmile Group, LLC › CLDX
Redmile Group, LLC 对 CLDX 的持仓历史
CELLDEX THERAPEUTICS INC NEW · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 CLDX(CELLDEX THERAPEUTICS INC NEW)433,921 股,市值约 US$16.1M,约占其申报组合的 1.08%,在其申报持仓中市值排名第 19 位。 Redmile Group, LLC 最近 12 个申报季度中有 12 个季度披露了 CLDX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 CLDX 的持仓演变
Redmile Group, LLC 于 Q3 2023 首次披露 CLDX 持仓:1,635,938 股(约 US$45.0M)。 在 12 次申报中,Redmile Group, LLC 1 次增持、10 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 433,921 股、市值约 US$16.1M,环比增持 172,413 股。。 持仓曾出现大幅变动:Q4 2023 减持约 39% (随后一个季度股价上涨 6%)、Q2 2025 减持约 42% (随后一个季度股价上涨 27%)、Q2 2026 增持约 66% (随后一个季度股价下跌 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.64M | $45.02M | 新进 |
| Q4 2023 | 993.80K | $39.41M | 减持 |
| Q1 2024 | 896.45K | $37.62M | 减持 |
| Q2 2024 | 718.72K | $26.60M | 减持 |
| Q3 2024 | 657.17K | $22.34M | 减持 |
| Q4 2024 | 615.77K | $15.56M | 减持 |
| Q1 2025 | 590.17K | $10.71M | 减持 |
| Q2 2025 | 343.03K | $6.98M | 减持 |
| Q3 2025 | 327.01K | $8.46M | 减持 |
| Q4 2025 | 283.31K | $7.69M | 减持 |
| Q1 2026 | 261.51K | $8.30M | 减持 |
| Q2 2026 | 433.92K | $16.15M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CLDX 与 13F 数据
CLDX(CELLDEX THERAPEUTICS INC NEW)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 CLDX,申报仓位最大的包括:Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CLDX 的基金
- Kynam Capital Management, LP 5.32M 股 · $198.07M · Q2 2026
- Deep Track Capital, LP 2.94M 股 · $109.37M · Q2 2026
- Logos Global Management LP 2.10M 股 · $78.14M · Q2 2026
- Eversept Partners, LP 1.79M 股 · $66.45M · Q2 2026
- Commodore Capital LP 1.35M 股 · $50.23M · Q2 2026
- Bellevue Group AG 1.20M 股 · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M 股 · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M 股 · $38.14M · Q2 2026
- Elmind Capital, LP 990.00K 股 · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K 股 · $32.73M · Q2 2026
- Affinity Asset Advisors, LLC 700.00K 股 · $26.05M · Q2 2026
- Rock Springs Capital Management LP 699.15K 股 · $26.02M · Q2 2026
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held CLDX?
Redmile Group, LLC has disclosed CLDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in CLDX?
As of Q2 2026, Redmile Group, LLC holds 433.92K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $16.15M, representing 1.08% of its reported portfolio and ranking #19.
Has Redmile Group, LLC been buying or selling CLDX?
In the latest 13F filing (Q2 2026), Redmile Group, LLC increased its position in CLDX.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.